On Friday, CorMedix Inc. (NYSEMKT:CRMD)’s shares declined -3.43% to $6.20.
CorMedix Inc. (CRMD) a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious diseases, recently declared a presentation on Neutrolin® post marketing surveillance data at the 52nd European Dialysis and Transplant Association (ERA-EDTA) Congress. The Neutrolin Usage Monitoring Program is a post-approval surveillance program monitoring the routine use of Neutrolin, a novel catheter lock solution, in hemodialysis patients with tunneled central venous catheters (CVC). The program measures the number of catheter related blood stream infections (CRBSI), and the number of pre-mature CVC removals due to infection and/ or thrombosis. The secondary outcome measure was biofilm formation in CVCs. Other outcome measures comprised of economic effects derived from using Neutrolin and effectiveness in the high risk groups (e.g. diabetic patients).
The poster, titled Neutrolin, A Catheter Lock Solution (CLS) with No Stated Human Resistance, Significantly Reduces the Rates of Infection and Thrombosis in Hemodialysis Patients Enrolled in a Post-Approval Surveillance Study, was presented on May 30, 2015. In 120 patients, the results to-date comprise three infections and two thromboses in 21,151 hemodialysis catheter-days. The Neutrolin Usage Monitoring Program results can be calculated as 0.14 infections per 1,000 catheter days (as compared to benchmark of 3.5 per 1,000 catheter days), a 96% reduction in infection rate, and 0.09 thrombosis per 1,000 catheter days (as compared to benchmark 2-3 per 1,000 catheter days), a 96% reduction in the rate of thrombosis.
CorMedix Inc., a pharmaceutical company, intends to in-license, develop, and commercialize therapeutic products for the prevention and treatment of cardiac, renal, and infectious diseases.
Northern Trust Corporation (NASDAQ:NTRS)’s shares gained 1.33% to $75.25.
Northern Trust Corporation (NTRS) has been selected to provide investment operations outsourcing services to RPMI Railpen, the in-house asset manager for the GB£21 billion (about US$32 billion) Railways Pension Scheme and a top 10 pension fund in the UK.
Under the terms of the agreement Northern Trust will provide trade matching, derivative processing and lifecycle administration, active collateral administration and book of record services.
Northern Trust Corporation, a financial holding company, provides asset servicing, fund administration, asset administration, fiduciary, and banking solutions for corporations, institutions, families, and individuals worldwide. It operates in two segments, Corporate & Institutional Services (C&IS) and Wealth Administration.
At the end of Friday’s trade, Vishay Intertechnology (NYSE:VSH)‘s shares dipped -0.47% to $12.68.
Vishay Intertechnology (VSH) introduced new high-voltage professional thin film MELF resistors in the 0204 and 0207 case sizes. Designed for industrial, lighting, and medical applications with high stability and reliability requirements, the Vishay Beyschlag MMA 0204 HV and MMB 0207 HV resistors combine a robust construction with industry-high operating voltages to 1000 V.
Built on an advanced metal film technology, the devices released recently provide proven reliability for high-voltage electronic circuits in lighting ballasts and LED drivers, industrial inverters and converters, battery administration systems, and medical equipment. In these applications, the resistors save board space and simplify designs by replacing devices in larger case sizes, multiple resistors in similar case sizes, and leaded resistors.
Vishay Intertechnology, Inc. manufactures and supplies discrete semiconductors and passive components in the United States, Europe, and Asia. The company operates in five segments: MOSFETs, Diodes, Optoelectronic Components, Resistors & Inductors, and Capacitors.
Fulton Financial Corp (NASDAQ:FULT), ended its Friday’s trading session with 1.48% gain, and closed at $13.02.
Fulton Financial Corp (FULT) stock coverage was initiated by analysts at Piper Jaffray with a “neutral” rating and a price target of $12.50.
Analysts believe that the company’s shares appear fairly valued given profitability and dividend yield and credit metrics are relatively in-line with peers.
However, risks comprise sustained low interest rates, which limits earning asset growth and inability to control increasing regulatory and compliance costs. Additionally, regional economic growth is predictable to remain in the low-single digits, according to the analyst note.
The Pennsylvania-based company offers a traditional array of bank products, but focuses primarily on commercial-related assets.
Fulton Financial Corporation operates as a multi-bank financial holding company that provides a range of banking and financial services to businesses and consumers. It offers personal banking services that comprise various checking account and savings deposit products, certificates of deposit, and individual retirement accounts.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
